Author

Xin Qin

Hubei University of Arts and SciencePrimary ORCID profile (0000-0002-4717-4310 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Xin QiniD1 paper · Chinese Academy of Sciences

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Eloiza May GaloniD· 1 shared Hang Li· 1 shared Lijun Jia· 1 shared Masahito AsadaiD· 1 shared Miako SakaguchiiD· 1 shared Mingming LiuiD· 1 shared Nanang Rudianto ArieftaiD· 1 shared Shengwei JiiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Eloiza May GalonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Efficacy and mechanism of action of cipargamin as an antibabesial drug candidate

Hang Li, Shengwei Ji, Nanang Rudianto Ariefta, Eloiza May Galon, Shimaa AES El-Sayed, Thom Do, Lijun Jia, Miako Sakaguchi, Masahito Asada, Yoshifumi Nishikawa, Xin Qin, Mingming Liu, Xuenan Xuan

This study evaluates cipargamin's efficacy against Babesia species and identifies resistance mechanisms, showing its effectiveness as an anti-babesial drug but limitations due to resistance, with combination therapy with tafenoquine offering potential.

eLife · Jun 2, 2025Peer-reviewedMicrobiology